When to choose cardiac resynchronization therapy in chronic heart failure: type and duration of the conduction delay

Cristina Balla1, Riccardo Cappato2

  • 1Cardiovascular Center, University of Ferrara, Ferrara, Italy.

Insights

Cardiac resynchronization therapy (CRT) improves heart failure (HF) outcomes. Patient selection for CRT is evolving, with left bundle branch block morphology now recognized as a key predictor of therapy response.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is a standard treatment for heart failure (HF) patients with impaired left ventricular (LV) function and wide QRS complex.
  • Initial CRT patient selection relied on QRS duration, but recent evidence highlights the importance of QRS morphology, particularly left bundle branch block (LBBB), for predicting treatment response.
  • Conventional right ventricular apical pacing can negatively impact cardiac structure and LV function, potentially causing or worsening HF.

Purpose of the Study:

  • To review current knowledge on selecting candidates for CRT.
  • To focus on how conduction delays causing LV electrical and mechanical dyssynchrony influence patient selection.
  • To emphasize the role of QRS morphology in optimizing CRT outcomes.

Main Methods:

  • Review of current scientific literature and clinical trial data on CRT patient selection.
  • Analysis of the impact of QRS duration versus QRS morphology (specifically LBBB) on CRT efficacy.
  • Examination of guidelines recommending CRT upgrades or de novo implantation based on pacing burden and LV function.

Main Results:

  • Left bundle branch block morphology is a significant predictor of positive response to CRT.
  • Guidelines now recommend CRT for patients with high ventricular pacing percentages and reduced ejection fraction (EF), considering upgrades or new implants.
  • Conduction delays leading to LV dyssynchrony are critical factors in CRT candidacy.

Conclusions:

  • Patient selection for CRT is increasingly refined beyond simple QRS duration to include specific QRS morphologies like LBBB.
  • Optimizing CRT candidate selection based on electrical dyssynchrony can improve therapeutic outcomes in heart failure patients.
  • CRT offers a valuable therapeutic option for selected HF patients, with evolving criteria enhancing its effectiveness.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
301
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.8K
Conduction System of the Heart01:20

Conduction System of the Heart

The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
3.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776